Euro HSP Federation

Euro HSP Federation EURO-HSP is a Federation of national associations related with a Rare Disease called Hereditary Spastic Paraplegia or Strümpell-Lorrain disease.

The Federation was made up during the project Rare! Together from EURORDIS.

02/04/2026

As Easter approaches, I would like to take a moment to send my warmest wishes to each of you.

Whether this season holds a religious meaning for you or simply represents a time of renewal and hope, it offers an opportunity to pause, reflect, and reconnect with what truly matters. In a time when the world is facing many challenges and uncertainties, I believe it is more important than ever to nurture a spirit of peace, solidarity, and shared humanity.

To our community, especially those living with HSP and PLS, I extend my deepest thoughts of support and closeness. Your strength, resilience, and commitment continue to inspire all every day.

May this period bring moments of calm, kindness, and connection — and may it remind us all of the importance of Standing Together.

Wishing you and your loved ones peace, hope, and gentle renewal.

M.



Tom Wahlig Stiftung
17/03/2026

Tom Wahlig Stiftung

An incredible symposium is behind us – and we are deeply grateful.

Two inspiring days of exchange, new insights, and meaningful conversations about Hereditary Spastic Paraplegia (HSP) have come to an end.

We would like to express our heartfelt thanks to everyone who made this symposium possible:
our speakers, researchers and clinicians, patients and families, all participants joining us on site and online – and the dedicated organizing team working tirelessly behind the scenes.

A special thank you goes to our host, the Knappschaft Kliniken Recklinghausen, for their support and excellent collaboration.

Events like this highlight the importance of international cooperation, open dialogue, and shared commitment to advancing research and improving perspectives for people living with HSP.

Thank you to everyone who contributed to making this symposium so meaningful.

Our scientific advisor taking some time to relax with Estelle’s book on HSP, recharging before participating in the HSP ...
07/03/2026

Our scientific advisor taking some time to relax with Estelle’s book on HSP, recharging before participating in the HSP Symposium organized by the Tom Wahlig Stiftung, starting next Wednesday.

It will be a valuable opportunity to meet researchers dedicated to HSP, exchange ideas, and continue working together toward better understanding and solutions for this condition. He will be presenting also the winner of the Adolf Struempell Prize 2026, Dr. Giulia Guarato. Emedea La Nostra Famiglia

Research moves forward through collaboration, passion, and moments like these.



You can find Estelle's book : https://amzn.eu/d/0hBwjNaY

"I’ve just published my book on Amazon. As a physiotherapist, I never imagined that one day I would be writing about my own journey. Developing hereditary spastic paraparesis (HSP) as an adult changed my life — but it didn’t take away my purpose. Instead, it pushed me to search for solutions, not only for myself, but for others living with HSP.

This self-help book comes from both my professional knowledge and my personal experience. The cover features a drawing I created myself, making this project even more meaningful to me." Estelle Marshall

Euro-HSP is pleased to announce that the Adolf-Struempell-Prize-2026 is awarded to Dr. Giulia Guarato ( Emedea  La Nostr...
03/03/2026

Euro-HSP is pleased to announce that the Adolf-Struempell-Prize-2026 is awarded to Dr. Giulia Guarato ( Emedea La Nostra FamigliaIRCCS E. Medea , Italy) for the paper entitled " Naringenin and SMER28 target lysosomal reformation and rescue SPG11 and SPG15 hereditary spastic paraplegia phenotypes".

The prize will be presented at the Tom Wahlig Symposium in Recklinghausen , Germany on March 13.https://www.hsp-info.de/fileadmin/Symposien/Recklinghausen_2026/TWS_Symposium_Program_2026.pdf

The study investigates the potential therapeutic effect of multiple target compounds for the treatment of the HSP subtypes SPG11 and SPG15 in a genetically modified animal model (drosophila, a small fly). Both subtypes share a common pathophysiological mechanism. The mutation causes an impairment in the function of the lysosomes – the cleaning and recycling units of cells. For SPG11 and SPG15 neurogeneration appears to be related to lysosomal malfunction. Two compounds – Naringenin and SMER28 – restored lysosomal parameters and improved locomotor function of the flies.

From the perspective of Euro-HSP in particular Naringenin might be of high interest. It is a natural compound being related to the consumption of citrus fruits. Furthermore, it is in use as a dietary supplement. Due to its antioxidant and anti-inflammatory effect Naringenin is known as a neuroprotective compound.

For translating finding obtained in a gene modified tiny fly to human patients some important work is strongly needed. This involves the identification of a safe but hopefully therapeutically beneficial dose for long-term therapy. This requires the quantification of potential curative effects by objectively accessible parameters in future clinical trials. However, when balancing the relatively low risk profile of Naringenin against the fatal outcome caused by untreated neurodegeneration in SPG11 and SPG15 such studies appear strongly needed and justified.

Euro-HSP is deeply committed to encourage and support this important work in the near future.

Euro-HSP is pleased to announce that the Adolf-Struempell-Prize-2026 is awarded to Dr. Giulia Guarato ( Emedea  La Nostr...
03/03/2026

Euro-HSP is pleased to announce that the Adolf-Struempell-Prize-2026 is awarded to Dr. Giulia Guarato ( Emedea La Nostra FamigliaIRCCS E. Medea , Italy) for the paper entitled " Naringenin and SMER28 target lysosomal reformation and rescue SPG11 and SPG15 hereditary spastic paraplegia phenotypes".

The prize will be presented at the Tom Wahlig Symposium in Recklinghausen , Germany on March 13.https://www.hsp-info.de/fileadmin/Symposien/Recklinghausen_2026/TWS_Symposium_Program_2026.pdf

The study investigates the potential therapeutic effect of multiple target compounds for the treatment of the HSP subtypes SPG11 and SPG15 in a genetically modified animal model (drosophila, a small fly). Both subtypes share a common pathophysiological mechanism. The mutation causes an impairment in the function of the lysosomes – the cleaning and recycling units of cells. For SPG11 and SPG15 neurogeneration appears to be related to lysosomal malfunction. Two compounds – Naringenin and SMER28 – restored lysosomal parameters and improved locomotor function of the flies.

From the perspective of Euro-HSP in particular Naringenin might be of high interest. It is a natural compound being related to the consumption of citrus fruits. Furthermore, it is in use as a dietary supplement. Due to its antioxidant and anti-inflammatory effect Naringenin is known as a neuroprotective compound.

For translating finding obtained in a gene modified tiny fly to human patients some important work is strongly needed. This involves the identification of a safe but hopefully therapeutically beneficial dose for long-term therapy. This requires the quantification of potential curative effects by objectively accessible parameters in future clinical trials. However, when balancing the relatively low risk profile of Naringenin against the fatal outcome caused by untreated neurodegeneration in SPG11 and SPG15 such studies appear strongly needed and justified.

Euro-HSP is deeply committed to encourage and support this important work in the near future.

https://amzn.eu/d/0hBwjNaY Today I’m feeling incredibly proud.I’ve just published my book on Amazon. As a physiotherapis...
02/03/2026

https://amzn.eu/d/0hBwjNaY

Today I’m feeling incredibly proud.

I’ve just published my book on Amazon. As a physiotherapist, I never imagined that one day I would be writing about my own journey. Developing hereditary spastic paraparesis (HSP) as an adult changed my life — but it didn’t take away my purpose. Instead, it pushed me to search for solutions, not only for myself, but for others living with HSP.

This self-help book comes from both my professional knowledge and my personal experience. The cover features a drawing I created myself, making this project even more meaningful to me.

Today I’m celebrating with a bus tour of Miami with Susie Ra, grateful for every moment. Even with this disability, life can be so beautiful and full of possibility. I truly believe we must always focus on what we can do, rather than what we can’t.

With hope and determination.

Estelle Marshall

Receiving a diagnosis of Hereditary Spastic Paraplegia (HSP) can be overwhelming and life-changing. Because HSP is a rare group of neurological conditions, many people have never heard of it before they are diagnosed. Alongside the physical symptoms come uncertainty, questions, and powerful emo...

On February 28, Rare Disease Day brought renewed attention to the two million people living in Italy with one of the 7,0...
02/03/2026

On February 28, Rare Disease Day brought renewed attention to the two million people living in Italy with one of the 7,000 identified genetic disorders—some of which now have a name and a therapy. Rare patients, each with their own story. Here is that of a 21-year-old from Lombardy, full of life and questions.

“I have SPG4, which isn’t a PlayStation model and is certainly less fun, but I live with it—it’s my normal.”

Twenty-one years old, with a soft “r” and striking looks, Edoardo has Spastic Paraplegia Type 4 (SPG4), a rare genetic disorder characterized by stiffness and muscle weakness in the lower limbs that can significantly affect mobility. Rare Disease Day has once again shone a spotlight on “rare patients” like him.

A testimonial for FONDAZIONE TELETHONFondazione Telethon, Edoardo receives rehabilitation care at the IRCCS Eugenio Medea – La Nostra Famiglia in Bosisio Parini (Lecco), a Lombardy referral center for rare diseases.

We meet at the Pia Grande swimming pool in Monza, where he trains with the Paralympic team ASD Silvia Tremolada. “I still need practice speaking and would like to improve my vocabulary. I’m too shy or insecure—I need to figure out which.” Without a doubt, Edoardo has a remarkable capacity for reflection and introspection—after all, he’s in his second year studying Psychology.

Edoardo, what’s your personality like?

Right now, I’m calm and peaceful. I like listening to people and observing others—that’s why I chose to study psychology. In sports, I’m always eager, maybe a bit too much. I should slow down, because in life, as in everything, it’s better to go step by step.

How do others look at you?

Young people are more open than older ones; they’re more inclusive, they look beyond what I have and understand that I can do many things—if not almost everything—just with more difficulty. What I can’t stand is when people stare at me and say, “I’m sorry.” Sorry for what? What do they know? I might live better than they do. Let me explain: at first it wasn’t easy, but little by little paraplegia became my normality. It’s part of my daily life, and I’ll live with it forever. It certainly doesn’t deprive me of the emotions, feelings, and experiences others have—if anything, it can give me a lot. I think any impactful experience changes you, and if you get through the down moment, you can only appreciate and be grateful for everything that happened.

What was your “down” moment?

After finishing high school, I had ten terrible months. I was confused and stayed in my room all day in front of the computer.

Then what happened? What made you turn things around?
Definitely swimming. My mom had already given me a push—she sent me on vacation with a friend, then to Lucca Comics and the ATP Finals. My family—my sister Margherita and my dad Tommaso—always supported me. I realized that you can do it, you can come out of your shell. The problem is that when I walk out the door—especially in Milan—I find barriers everywhere: stairs, missing elevators. It’s as if the outside world tells me, “Go back home.” Then, thanks to a friend, Maria Pia, we found the Tremolada competitive team. And that’s when my life changed.

Do you feel different now?

Absolutely! I was a teenager, with everything that comes with that. Now, thanks to swimming, I’m becoming calm and centered again. I also go to schools to talk to children about my experience. They’re very shy but curious, especially about the competitive side. I tell them about the thrill of racing, the desire to push yourself and do more. In life, you need a goal—it helps with everything else. Swimming is my motivation.

Do you have many friends?

Let’s say I have room for improvement. I don’t know if I’d call myself individualistic, but I think the hardest thing is being happy with yourself. Often, others create unnecessary problems. I feel comfortable with people similar to me, who’ve gone through difficult life experiences. I’m not only referring to illness, but also to those “down” periods that, sooner or later, we all go through.

How do you see your future?

I don’t know. I’d like to do something that combines what I’m studying with sports. For now, though, I live more in the present.

Do you like your life?

I consider myself quite lucky. I spent two weeks alone in Liverpool, I’ve been on television, I’ve traveled and done things some people may never do in a lifetime—experiences that taught me a lot, journeys of introspection, special encounters. But there are others worse off than me who aren’t independent. That’s why research is important: it can improve the quality of life for so many people.

According to specialist Maria Grazia D’Angelo, “When it comes to rare diseases, the key is collaboration. A rare disease affects every area of a person’s life—especially when we’re talking about a child.” D’Angelo heads the Specialized Rehabilitation Unit for Rare Diseases of the Central and Peripheral Nervous System at the Medea Institute. “Family, school, recreational and sports environments, and hospital facilities that monitor or treat the underlying condition are all spaces where the support and integration process takes place, with significant emotional impact.”

At IRCCS Eugenio Medea – La Nostra Famiglia, rare diseases have increasingly occupied a significant role, both in inpatient care across its various hospital sites and in outpatient services. “The advent of new molecular diagnostic technologies,” Dr. D’Angelo continues, “has made it possible to identify a growing number of rare diseases primarily affecting the nervous system. This has opened new paths for research and clinical trials, but also requires more comprehensive care involving multiple medical and rehabilitation professionals.”

A disease is defined as rare based on its low prevalence in a given population (in the EU, fewer than 5 people per 10,000). Collectively, however, rare diseases represent a public health emergency: around 7,000–8,000 have been identified, and they are estimated to affect over 300–400 million people worldwide—about 6–8% of the global population. They are chronic conditions, mostly genetic in origin, and only about a thousand have specific treatments. In Italy, more than two million people are living with a rare disease; 70% are children, and 40% are affected by conditions involving the central and peripheral nervous system and muscles.

Avvenire



https://www.avvenire.it/vita-e-cura/gli-amici-il-nuoto-il-futuro-tutto-da-scrivere-la-storia-di-edoardo-ragazzo-raro-come-la-sua-malattia_105249

28/02/2026

Together on Rare Disease Day, the best way to share experiences, knowledge, science.

For the HSP/PLS Community, one step forward, Together!

Adresse

99 Rue Didot
Paris
75014

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque Euro HSP Federation publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.

Contacter L’organisation

Envoyer un message à Euro HSP Federation:

Partager